Department of Pharmacy, Southeast University, Dhaka, Bangladesh.
Department of Chemistry, University of Swabi, Anbar 23561, Khyber Pakhtunkhwa, Pakistan.
Curr Protein Pept Sci. 2020;21(12):1193-1201. doi: 10.2174/1389203721666200923153406.
The ubiquitin (Ub)-proteasome system (UPS) targets various cellular proteins for degradation. It has been found that defects in the UPS play a crucial role in the pathogenesis of Alzheimer's disease (AD), as the existence of Ub immunoreactivity in AD-linked neuronal inclusions, including neurofibrillary tangles, is observed in all types of AD cases. Current investigations have shown that components of the UPS can be connected with the early stage of AD, which is characterized by synaptic dysfunction, and to the late phases of the disease, marked by neurodegeneration. Although the significance of UPS in the pathogenesis of AD has been emphasized, targeted treatment at the main components of these pathways has a great perspective in advancing new therapeutic interventions for AD. In this review, we emphasize the relationship between UPS and AD pathology. We also represent the recent therapeutic advancements targeting UPS components in AD.
泛素(Ub)-蛋白酶体系统(UPS)靶向各种细胞蛋白进行降解。已经发现,UPS 的缺陷在阿尔茨海默病(AD)的发病机制中起着关键作用,因为在 AD 相关神经元包含物(包括神经原纤维缠结)中存在 Ub 免疫反应性,这在所有类型的 AD 病例中都观察到。目前的研究表明,UPS 的成分可以与 AD 的早期阶段(以突触功能障碍为特征)以及疾病的晚期(以神经退行性变为标志)相关联。尽管 UPS 在 AD 发病机制中的重要性已经得到强调,但针对这些途径的主要成分的靶向治疗在推进 AD 的新治疗干预方面具有广阔的前景。在这篇综述中,我们强调了 UPS 与 AD 病理学之间的关系。我们还介绍了针对 AD 中 UPS 成分的最新治疗进展。